drugset / Trial / NCT00736606

A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers

NCT00736606

Phase 1 Completed 12 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the pharmacokinetics of both AZD9056 (steady state) and simvastatin (single dose) when co-administered in healthy volunteers

Timeline

Start
2008-08
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD9056 Small molecule 400 mg
Subject Simvastatin Small molecule 40 mg

Indications

No indication recorded.